Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon

Remote monitoring may reduce hospitalizations costs in patients with cardiac implants

In May 2015, the Heart Rhythm Society released a consensus statement recommending that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices. The panel argued that remote monitoring helped check the devices’ electronic integrity and functionality and improved patient adherence.

Cardiostim 2016: Growing Importance of Remote Monitoring and Potential for New Heart Monitor Indications Detailed at Scientific Session

(PresseBox) BIOTRONIK Home Monitoring® received strong endorsements during the Cardiostim scientific session “Improving Patient Outcomes in Arrhythmia Management.” 

Medtronic Announces FDA Approval and Launch of World's First App-Based Remote Monitoring System for Pacemakers

Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial availability of the MyCareLink Smart(TM) Monitor, the world's first app-based remote monitoring system for patients with implantable pacemakers.

FDA approves app-based remote monitoring system for patients with implantable pacemakers

On Nov. 17, the FDA approved the MyCareLink Smart Monitor, the first app-based remote monitoring system in the U.S. for patients with implantable pacemakers.

Thumbnail

HRS statement recommends remote monitoring as standard of care

A panel of experts recommended that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices (CIEDs), according to a consensus statement from the Heart Rhythm Society (HRS). The statement was published online in Heart Rhythm on May 13.

Data shows the CardioMEMS HF System adds incremental benefit when combined with device therapy and is cost effective

St. Jude Medical, Inc., a global medical device company, today announced important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS™ HF System for the management of Class III heart failure patients.

Thumbnail

The disconnect in remote monitoring

The evidence favors remote monitoring using implantable cardiac devices yet few take advantage of the resource.

Thumbnail

HRS.15: Remote monitoring leads to cost savings, fewer hospitalizations

BOSTON—Patients who had remote monitoring in their implantable electronic cardiac devices had lower all-cause hospitalization costs and recurrent hospitalizations compared with patients without remote monitoring capabilities, according to a large, retrospective, cohort study.

Displaying 113 - 120 of 130

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup